CBS 2019
CBSMD教育中心
中 文

经皮左心耳封堵

Abstract

Recommended Article

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Original Research2021 Feb 27;S1547-5271(21)00182-X.

JOURNAL:Heart Rhythm. Article Link

Does pulsed field ablation regress over time? A quantitative temporal analysis of pulmonary vein isolation

I Kawamura, P Neuzil, P Shrivamurthy et al. Keywords: atrial fibrillation; electroporation; level of isolation; pulmonary vein isolation; pulsed field ablation

Full Text PDF